Home Authors Posts by Karen Friar

Karen Friar

106 POSTS 0 COMMENTS
http://pradeshtak.com
Sharp Sell-off Grips Dalal Street: BSE Sensex Plummets Nearly 1,000 Points
Business

Sharp Sell-off Grips Dalal Street: BSE Sensex Plummets Nearly 1,000 Points

Karen Friar -
0
Intel Appoints Lip-Bu Tan as CEO: A New Era for the Struggling Chip Giant?
Business

Intel Appoints Lip-Bu Tan as CEO: A New Era for the Struggling Chip Giant?

Karen Friar -
0
U.S. Stocks Slide as UnitedHealth Probe and Economic Woes Weigh on Markets
Business

U.S. Stocks Slide as UnitedHealth Probe and Economic Woes Weigh on Markets

Karen Friar -
0
UnitedHealth Group (NYSE:UNH) Shares Plunge 7% Amid DOJ Fraud Investigation
Business

UnitedHealth Group (NYSE:UNH) Shares Plunge 7% Amid DOJ Fraud Investigation

Karen Friar -
0
Wall Street Struggles for Direction Amid Walmart’s Outlook and UnitedHealth Investigation
Business

Wall Street Struggles for Direction Amid Walmart’s Outlook and UnitedHealth Investigation

Karen Friar -
0
FDA Declares End to Semaglutide Shortage, Grants Grace Period for Compounders
Business

FDA Declares End to Semaglutide Shortage, Grants Grace Period for Compounders

Karen Friar -
0
Hims & Hers Acquires Peptide Facility Amid Weight Loss Drug Shift, Stock Drops 20%
Business

Hims & Hers Acquires Peptide Facility Amid Weight Loss Drug Shift, Stock Drops 20%

Karen Friar -
0
FDA Declares End to Ozempic and Wegovy Shortages, Impacting Hims & Hers Health (NYSE:HIMS)
Business

FDA Declares End to Ozempic and Wegovy Shortages, Impacting Hims & Hers Health (NYSE:HIMS)

Karen Friar -
0
Arbor Realty Trust (NYSE:ABR) Q4 2024 Earnings and Dividend Announcement
Business

Arbor Realty Trust (NYSE:ABR) Q4 2024 Earnings and Dividend Announcement

Karen Friar -
0
Goldman Sachs Reveals Stocks with Biggest Short Interest Shifts Since U.S. Election
Business

Goldman Sachs Reveals Stocks with Biggest Short Interest Shifts Since U.S. Election

Karen Friar -
0
Bluebird Bio (NASDAQ:BLUE) to Go Private in $3 Billion M&A Deal with Carlyle and SK Capital
Business

Bluebird Bio (NASDAQ:BLUE) to Go Private in $3 Billion M&A Deal with Carlyle and SK Capital

Karen Friar -
0
Apple (NASDAQ:AAPL) Removes Advanced Data Protection in the UK Amid Government Pressure
Business

Apple (NASDAQ:AAPL) Removes Advanced Data Protection in the UK Amid Government Pressure

Karen Friar -
0
Coinbase (NASDAQ:COIN) Surges as SEC Agrees to Dismiss Lawsuit with No Fines
Business

Coinbase (NASDAQ:COIN) Surges as SEC Agrees to Dismiss Lawsuit with No Fines

Karen Friar -
0
Virtus InfraCap U.S. Preferred Stock ETF (NYSEARCA:PFFA) Declares $0.1700 Dividend for February 2024
Business

Virtus InfraCap U.S. Preferred Stock ETF (NYSEARCA:PFFA) Declares $0.1700 Dividend for February 2024

Karen Friar -
0
Kenvue (NYSE:KVUE) Rises on Takeover Speculation Amid Activist Pressure
Business

Kenvue (NYSE:KVUE) Rises on Takeover Speculation Amid Activist Pressure

Karen Friar -
0
Arbor Realty Trust (NYSE:ABR) Posts Mixed Q4 Results as Earnings Miss but NII Beats Estimates
Business

Arbor Realty Trust (NYSE:ABR) Posts Mixed Q4 Results as Earnings Miss but NII Beats Estimates

Karen Friar -
0
J.P. Morgan Upgrades Grab Holdings (GRAB) to Overweight, Sees Strong Earnings Growth Ahead
Business

J.P. Morgan Upgrades Grab Holdings (GRAB) to Overweight, Sees Strong Earnings Growth Ahead

Karen Friar -
0
Goldman Sachs Identifies Key Hedge Fund Shifts Following Post-Election Policies
Business

Goldman Sachs Identifies Key Hedge Fund Shifts Following Post-Election Policies

Karen Friar -
0
Arbor Realty Trust (NYSE:ABR) Q4 2024 Earnings: EPS and Revenue Fall Short of Expectations
Business

Arbor Realty Trust (NYSE:ABR) Q4 2024 Earnings: EPS and Revenue Fall Short of Expectations

Karen Friar -
0
Gilead Seladelpar Wins EU Approval for Rare Liver Disease Treatment
Business

Gilead Seladelpar Wins EU Approval for Rare Liver Disease Treatment

Karen Friar -
0
123...6Page 1 of 6
© Newspaper WordPress Theme by TagDiv